Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a virtual classroom help kids with ADHD as much as pills?

NCT ID NCT01821170

Disease control Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three ways to help children aged 7-11 with ADHD: a computer-based cognitive training program using a virtual classroom, the medication methylphenidate, and supportive talk therapy. Fifty-one children took part to see which approach best improves attention and reduces hyperactivity. The goal was to find effective alternatives to medication, which can have side effects like sleep problems and loss of appetite.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
methylphenidate
What this could lead to
If successful, this could show that a computer-based training program is a useful alternative or addition to medication for managing ADHD symptoms.
What could go wrong
This is a small, completed study with only 51 participants, so results may not apply to all children. The cognitive remediation approach may not work as well as medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

51 people

The number who actually took part.

Started

Apr 2013

Finished

Apr 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 11 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient, male or female, aged 7 to 11 years, * Responding to current diagnostic criteria for ADHD according to DSM IV-TR (Diagnostic and Statistical Manual of Mental Disorders), * Presenting a total score on the ADHD-RS (ADHD Rating Scale)\> 28 (before treatment), * Schooled in conventional class, * Presenting a WISC (Wechsler Intelligence Scale for Children) IV total score\> 80 (done before or in follow-up), * Registered to social security, * Legal represent has given informed consent to participate in the study. Exclusion Criteria: * Uncorrected perceptual disorder, * Patient treated by psychostimulant, * Patient under supportive psychotherapy, * Patient treated by methylphenidate, * Subjects with a pervasive developmental disorder, psychotic disorder, characterized major depressive disorder, * Subjects who participated in research in the last 3 months, * Subjects suffering from: glaucoma, hyperthyroidism, thyrotoxicosis, heart diseases (high blood pressure, congestive heart failure, etc…), cerebrovascular disorders, * Subjects with no deficit in the virtual classroom: having a total number of hit superior to 80 and a number of commissions inferior to 21.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, 33000, France

  • Centre Hospitalier Charles Perrens

    Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.